Effects of H2 blockers and omeprazole on peptic secretion: a prospective, randomized study in duodenal ulcer subjects

Acta Gastroenterol Belg. 1993 Mar-Apr;56(2):223-8.

Abstract

Aim of the present study has been to investigate the possible modifications of peptic secretion after a period with H2 blockers and omeprazole, evaluating in the same patient pepsinogen group A levels in gastric mucosa and pepsin in gastric juice. 54 active duodenal ulcer were studied: during an upper gastrointestinal endoscopy a sample of gastric juice and one fundus biopsy were taken before and after four weeks 300 mg/daily ranitidine (23 patients), 40 mg/daily famotidine (7 patients), 300 mg/daily nizatidine (12 patients) therapy and 40 mg/daily omeprazole (12 patients) therapy.

Results: H2-blockers and omeprazole treatment determines a non statistically significant decrease of pepsin in gastric juice and in pepsinogen group A in gastric mucosa.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Duodenal Ulcer / drug therapy*
  • Duodenal Ulcer / metabolism
  • Famotidine / therapeutic use
  • Female
  • Histamine H2 Antagonists / therapeutic use*
  • Humans
  • Infant, Newborn
  • Male
  • Middle Aged
  • Nizatidine / therapeutic use
  • Omeprazole / therapeutic use*
  • Pepsin A / metabolism*
  • Pepsinogens / metabolism
  • Prospective Studies
  • Ranitidine / therapeutic use

Substances

  • Histamine H2 Antagonists
  • Pepsinogens
  • Famotidine
  • Ranitidine
  • Pepsin A
  • Omeprazole
  • Nizatidine